ModelEdge
Arca Biopharma Inc.
ABIO
Filing type
S-3
Filing date
Aug 20, 2026
Updated
Aug 21, 2026 ยท 2:18 PM

Filing

S-3Registration Statement for Securities Offered under a Shelf Registration

Exhibits

EX-1.3AMENDMENT NO. 1 TO THE SALES AGREEMENT BETWEEN ORUKA THERAPEUTICS, INC. AND TD SECURITIES (USA) LLC, DATED AUGUST 21, 2026EX-5.1OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE BASE PROSPECTUSEX-5.2OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE SALES AGREEMENT PROSPECTUSEX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMEX-FILING FEESFILING FEE TABLEGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic